The first case of levetiracetam-induced and tolvaptan-resistant hyponatremia
Hyponatremia is frequently seen in heart failure patients and has a high mortality rate. If not treated adequately, acute and chronic hyponatremia may worsen the prognosis of heart failure. Despite its high incidence in heart failure patients, other underlying conditions that possibly lead to the in...
Main Authors: | Fatih Kahraman, Hatem Ari, Murat Baver Acaban |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2015-04-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-45735 |
Similar Items
-
Use of tolvaptan in patients hospitalized for worsening chronic heart failure with severe hyponatremia: The initial experience at a single-center in Turkey
by: Saim Sağ, et al.
Published: (2017-07-01) -
Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma
by: Fatih Gürbüz, et al.
Published: (2019-06-01) -
Hyponatremia in stroke
by: Sheikh Saleem, et al.
Published: (2014-01-01) -
Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial
by: Elangovan Shanmugam, et al.
Published: (2016-04-01) -
Tolvaptan
by: Bharath Rangarajan, et al.
Published: (2014-01-01)